Topics

A New Adjunctive Approach for Patients with Treatment-Refractory Depression

14:57 EDT 11 Oct 2019 | NEJM

Adjunctive use of an antipsychotic used in Parkinson disease is associated with improvement in depression by week 1, which is sustained through week 5.

Original Article: A New Adjunctive Approach for Patients with Treatment-Refractory Depression

NEXT ARTICLE

More From BioPortfolio on "A New Adjunctive Approach for Patients with Treatment-Refractory Depression"

Quick Search

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...